STOCK TITAN

CEL-SCI (NYSE: CVM) trust buys 300K restricted shares at $1.20

Filing Impact
(High)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

CEL SCI CORP director and CEO Geert Kersten reported a significant insider purchase through a related trust. On May 14, 2026, the de Clara Trust, for which Mr. Kersten serves as trustee, bought 300,000 shares of restricted common stock directly from the company at $1.20 per share, equal to the most recent closing price on May 13, 2026.

After this transaction, Mr. Kersten is shown with 210,950 common shares held directly and 311,547 common shares held indirectly as trustee of the de Clara Trust. The filing shows no derivative securities remaining after this activity.

Positive

  • None.

Negative

  • None.
Insider KERSTEN GEERT R
Role Chief Executive Officer
Bought 300,000 shs ($360K)
Type Security Shares Price Value
Purchase Common Stock 300,000 $1.20 $360K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 311,547 shares (Indirect, Trustee); Common Stock — 210,950 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Restricted shares purchased 300,000 shares Bought by de Clara Trust on May 14, 2026
Purchase price $1.20 per share Equal to May 13, 2026 closing price
Direct common shares after 210,950 shares Direct holdings following reported transactions
Indirect common shares after 311,547 shares Held indirectly as trustee of de Clara Trust
Net share direction 300,000 net-buy shares Form 4 transaction summary for common stock
restricted stock financial
"purchased 300,000 shares of restricted stock directly from the Company"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
trustee financial
"the de Clara Trust, of which Mr. Kersten is a trustee, purchased"
A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.
indirect financial
"311,547 common shares held indirectly as trustee of the de Clara Trust"
open-market purchase financial
"transaction_action": "open-market purchase""
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
Form 4 financial
"according to the ownership details disclosed in the Form 4 filing"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KERSTEN GEERT R

(Last)(First)(Middle)
8229 BOONE BLVD
STE 802

(Street)
VIENNA VIRGINIA 22182

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CEL SCI CORP [ CVM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/14/2026P300,000(1)A$1.2311,547ITrustee
Common Stock210,950D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. On May 14, 2026, the de Clara Trust, of which Mr. Kersten is a trustee, purchased 300,000 shares of restricted stock directly from the Company at the closing price on May 13, 2026, the most recent closing price available.
Geert Kersten05/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CEL SCI CORP (CVM) report for Geert Kersten?

CEL SCI CORP reported that the de Clara Trust, with CEO Geert Kersten as trustee, purchased 300,000 restricted common shares. The shares were bought directly from the company, reflecting an increase in insider-associated ownership through a related trust structure.

At what price did the de Clara Trust buy CEL SCI CORP (CVM) shares?

The de Clara Trust bought 300,000 CEL SCI CORP shares at $1.20 per share. This price matched the May 13, 2026 closing price, described as the most recent closing price available for the restricted stock transaction with the company.

How many CEL SCI CORP shares does Geert Kersten hold after this Form 4?

After the reported transactions, Geert Kersten holds 210,950 common shares directly and 311,547 common shares indirectly. The indirect holdings are as trustee of the de Clara Trust, according to the ownership details disclosed in the Form 4 filing.

Was the CEL SCI CORP insider transaction an open-market purchase?

The coded transaction is categorized as an open-market or private purchase, but the footnote clarifies that the de Clara Trust bought 300,000 restricted shares directly from CEL SCI CORP at the most recent closing price, rather than through a public market trade.

Did the CEL SCI CORP Form 4 show any option exercises or derivative trades?

The Form 4 does not list any option exercises or derivative security trades. The derivative transactions count is zero, and the filing focuses on common stock positions held directly and indirectly following the trust’s restricted stock purchase.